Results 181 to 190 of about 43,858 (197)

Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma

Journal of Dermatological Science, 2021
Chenyang Wang, Kie Mizumaki, Ai Okamura   +2 more
exaly  

Spectrophotometric method to quantify tofacitinib in lyotropic liquid crystalline nanoparticles and skin layers: Application in ex vivo dermal distribution studies

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2021
Gorantla Srividya, Gautam Singhvi, Ranendra N Saha   +2 more
exaly  

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Lancet, The, 2017
Robert Moots, Sergey Yakushin, Dror Mevorach   +2 more
exaly  

Tofacitinib for the Treatment of Steroid-Induced Rosacea

Clinical, Cosmetic and Investigational Dermatology, 2022
exaly  

Systematic Review of Tofacitinib: A New Drug for the Management of Rheumatoid Arthritis

Clinical Therapeutics, 2014
Kirandeep Kaur, Sonesh Kalra, Sandeep Kaushal   +2 more
exaly  

Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies

International Journal of Rheumatic Diseases, 2016
Joel Kremer, Yoshiya Tanaka, Roy Fleischmann   +2 more
exaly  

Impact of tofacitinib treatment on human B-cells in vitro and in vivo

Journal of Autoimmunity, 2017
Nils Venhoff, Julian Staniek, Marta Rizzi   +2 more
exaly  

Tofacitinib

Reactions Weekly, 2016
openaire   +1 more source

The off-label uses profile of tofacitinib in systemic rheumatic diseases

International Immunopharmacology, 2020
Cong Ye, Zichu Zhao, Lingli Dong
exaly  

Tofacitinib

Reactions Weekly, 2017
openaire   +1 more source